Citations - McCluggage W. Glenn

The European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian germ cell tumours, sex cord-stromal tumours, and small cell carcinoma... Read more
Published on: 2020-07-03
Source: McCluggage W. Glenn
By: Cristiana Sessa
The European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian germ cell tumours, sex cord-stromal tumours, and small cell carcinoma... Read more
Published on: 2020-07-03
Source: McCluggage W. Glenn
By: Cristiana Sessa
The European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian germ cell tumours, sex cord-stromal tumours, and small cell carcinoma... Read more
Published on: 2020-07-03
Source: McCluggage W. Glenn
By: Cristiana Sessa
Endometrial carcinoma programmed death-ligand 1 (PD-L1) expression in tumor cells (TCs) and tumor-associated inflammatory cells (ICs) have recently been reported in several studies which vary in terms of their cohort size, design, and methodology. We aimed to assess PD-L1 staining in endometrial carcinomas and correlate this with clinical and pathological... Read more
Published on: 2020-06-29
Source: McCluggage W. Glenn
By: Gozde Kir
Endometrial carcinoma programmed death-ligand 1 (PD-L1) expression in tumor cells (TCs) and tumor-associated inflammatory cells (ICs) have recently been reported in several studies which vary in terms of their cohort size, design, and methodology. We aimed to assess PD-L1 staining in endometrial carcinomas and correlate this with clinical and pathological... Read more
Published on: 2020-06-29
Source: McCluggage W. Glenn
By: Gozde Kir
Endometrial carcinoma programmed death-ligand 1 (PD-L1) expression in tumor cells (TCs) and tumor-associated inflammatory cells (ICs) have recently been reported in several studies which vary in terms of their cohort size, design, and methodology. We aimed to assess PD-L1 staining in endometrial carcinomas and correlate this with clinical and pathological... Read more
Published on: 2020-06-29
Source: McCluggage W. Glenn
By: Gozde Kir
Endometrial carcinoma programmed death-ligand 1 (PD-L1) expression in tumor cells (TCs) and tumor-associated inflammatory cells (ICs) have recently been reported in several studies which vary in terms of their cohort size, design, and methodology. We aimed to assess PD-L1 staining in endometrial carcinomas and correlate this with clinical and pathological... Read more
Published on: 2020-06-29
Source: McCluggage W. Glenn
By: Gozde Kir
No abstract... Read more
Published on: 2020-06-24
Source: McCluggage W. Glenn
By: W Glenn McCluggage
Modern classification schemes divide cervical adenocarcinomas into human papillomavirus (HPV)-associated and HPV-independent types. The precursor lesions of the former are well known and comprise HPV-associated (usual/endocervical) adenocarcinoma in situ (AIS) and the much less common stratified mucin-producing intraepithelial lesion (SMILE). The precursor lesions of HPV-independent cervical adenocarcinomas are much less... Read more
Published on: 2020-06-03
Source: McCluggage W. Glenn
By: Simona Stolnicu
No abstract... Read more
Published on: 2020-05-18
Source: McCluggage W. Glenn
By: Murali Varma
  • Other

    Citations

  • Other

    Citations

Translate »